![rare diseases](https://www.sciensus.com/wp-content/uploads/2024/02/Website_1920x700_v5.jpg)
We connect people with life-changing medicine
Our insights help each and every patient make the most of their medicine to keep their lives on track.
Our key markets
We provide bespoke end-to-end services in our key markets to connect pharmaceutical companies, insurers and healthcare professionals to patients.
Rare diseases
We’re a global network dedicated to getting rare and orphan medicines to hard-to-reach patients worldwide.
Intelligent Insights
Our Intelligent Insights are enabling healthcare professionals, pharmaceutical companies and biotechs to improve patient health outcomes.
Long-term conditions
As a leading life science business, we help those with long-term conditions get the best from their medicines.
Cancer treatments
Delivering a range of treatments, we are the UK’s leading provider of cancer in-home care.
As a strategic partner, they have exceeded our expectations by finding global patients, who need our drugs, and enabling them to receive their life-extending medications.
Chief Commercial Officer at Eiger BioPharmaceuticals, Inc.
News and Insights
Stay up to date with the news and learn from our experts across Sciensus.
![](https://www.sciensus.com/wp-content/uploads/2024/07/MGP_9099-2-640x427.jpg)
News
Jonathan Asbridge selected as a Fellow of the American Academy of Nursing
Sciensus is pleased to announce that Professor Sir Jonathan Asbridge, Chief Clinical Officer at Sciensus, has been selected to become…
![Healthcare professionals talking](https://www.sciensus.com/wp-content/uploads/2023/10/Sciensus-partnerships-640x427.jpg)
Gated Content
Safety first: Profiling adverse events in cancer drug therapies
![Family walking on hill](https://www.sciensus.com/wp-content/uploads/2023/10/MicrosoftTeams-image-11-1-640x233.jpg)
Gated Content
The power of patient insight: Understanding the drivers of adherence and persistence